Drug Discovery at Dundee
The Wellcome Trust, one of the world’s largest medical charities, has awarded £8.1 million over 5 years to a team of six scientists at the University of Dundee to help discover new drugs to treat some of the world’s most neglected tropical diseases.
The grant awarded to Professor Mike Ferguson, Professor Alan Fairlamb, Professor Bill Hunter, Professor Ian Gilbert, Professor Julie Frearson and Dr Daan van Aalten, all based within the School of Life Sciences at the University, is among the largest given by the Wellcome Trust.
No vaccines exist to prevent these debilitating and often lethal infections. Many of the current drugs have serious side effects and would not meet current standards for safety and efficacy. Others are either too expensive for widespread use or becoming less effective because of resistance.
The University of Dundee team are renowned for their academic contributions to tropical disease research. Together, they integrate many disciplines directed towards the discovery of new therapies for tropical diseases.
The £8.1 million grant will allow them to add a team of 16 scientists to their existing 60 and to span all the disciplines needed to go from biology to drug design, synthesis and testing. The new activities will be housed in the newly completed Centre for Interdisciplinary Research at the University, a £20 million building specialising in tropical disease research, diabetes and cancer. Professors Ferguson said, “We are delighted with the enthusiasm, good-will and financial support we have received from The University and the Wellcome Trust to get this underway. This initiative will have a major impact on those suffering from these appalling diseases.”
The total project, including the construction and equipping of the new state-of-the-art laboratories, will cost about £13 million over the next 5 years. While the lion’s share of the additional research and development activity will be met by the Wellcome Trust award, very significant investments in infrastructure and academic appointments have been made by The University of Dundee itself, by the Scottish Higher-Education Funding Council (in the form of a strategic research development grant of £1.5 million to Dundee, Glasgow and St Andrews Universities) and by The Wolfson Foundation, who gave £2 million to help construct the new laboratories.
Professor Ferguson commented “Getting all the pieces in place to carry out a serious drug discovery programme in an academic environment is virtually unprecedented and quite demanding. Everyone in the team has done a fantastic job. We all bring different blends of scientific expertise to the project and, most importantly, share the vision of translating our knowledge into new therapies for neglected diseases.
“We are particularly pleased to welcome on board Professor Julie Frearson, recruited from the company Cambridge BioFocus plc, who will set up and oversee our compound screening facility, Professor Ian Gilbert, recruited from Cardiff University, who will supervise the medicinal chemistry, and Dr Ruth Brenk, recruited from The University of California, San Francisco, who will bolster our computational chemistry and drug design.”
Dr Mark Walport, Director of the Wellcome Trust said, “Many drugs currently used to treat important diseases in the world’s poorest countries, such as sleeping sickness and leishmaniasis, are no longer effective and may have serious side effects. “We hope that this exciting project will translate the insights arising from basic research into new or improved treatments for the millions of people whose lives and livelihoods are threatened daily by tropical infectious diseases.
“Wellcome Trust funding is bridging a wide funding gap in the UK allowing health researchers involved in early-stage drug discovery projects to advance promising innovations to a stage where they become attractive to public/private partnerships and the commercial sector for further development.”
Roddy Isles | alfa
Chances to treat childhood dementia
24.07.2017 | Julius-Maximilians-Universität Würzburg
World first: Massive thrombosis removed during early pregnancy
20.07.2017 | Universitätsspital Bern
Physicists have developed a new technique that uses electrical voltages to control the electron spin on a chip. The newly-developed method provides protection from spin decay, meaning that the contained information can be maintained and transmitted over comparatively large distances, as has been demonstrated by a team from the University of Basel’s Department of Physics and the Swiss Nanoscience Institute. The results have been published in Physical Review X.
For several years, researchers have been trying to use the spin of an electron to store and transmit information. The spin of each electron is always coupled...
What is the mass of a proton? Scientists from Germany and Japan successfully did an important step towards the most exact knowledge of this fundamental constant. By means of precision measurements on a single proton, they could improve the precision by a factor of three and also correct the existing value.
To determine the mass of a single proton still more accurate – a group of physicists led by Klaus Blaum and Sven Sturm of the Max Planck Institute for Nuclear...
The research team of Prof. Dr. Oliver Einsle at the University of Freiburg's Institute of Biochemistry has long been exploring the functioning of nitrogenase....
A one trillion tonne iceberg - one of the biggest ever recorded -- has calved away from the Larsen C Ice Shelf in Antarctica, after a rift in the ice,...
Physics supports biology: Researchers from PTB have developed a model system to investigate friction phenomena with atomic precision
Friction: what you want from car brakes, otherwise rather a nuisance. In any case, it is useful to know as precisely as possible how friction phenomena arise –...
21.07.2017 | Event News
19.07.2017 | Event News
12.07.2017 | Event News
21.07.2017 | Earth Sciences
21.07.2017 | Power and Electrical Engineering
21.07.2017 | Physics and Astronomy